These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39352728)

  • 1. Atrial fibrillation in transthyretin amyloidotic cardiomyopathy: prevalence and echocardiographic predictors.
    Rodríguez MR; Spaccavento A; Diez M; Conde D; Burgos LM; Seia IM; Meretta A; Baranchuk A; Gupta S; Costabel JP
    Minerva Cardiol Angiol; 2024 Oct; ():. PubMed ID: 39352728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
    Gonzalez-Lopez E; Escobar-Lopez L; Obici L; Saturi G; Bezard M; Saith SE; AbouEzzeddine OF; Mussinelli R; Gagliardi C; Kharoubi M; Griffin JM; Dispenzieri A; Vilches S; Perlini S; Longhi S; Oghina S; Rivas A; Grogan M; Maurer MS; Damy T; Palladini G; Rapezzi C; Garcia-Pavia P
    JACC CardioOncol; 2022 Nov; 4(4):442-454. PubMed ID: 36444226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis.
    Meucci MC; Lillo R; Mango F; Marsilia M; Iannaccone G; Tusa F; Luigetti M; Biagini E; Massetti M; Lanza GA; Lombardo A; Graziani F
    Int J Cardiol; 2024 May; 402():131891. PubMed ID: 38382852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis.
    Sinigiani G; De Michieli L; Porcari A; Zocchi C; Sorella A; Mazzoni C; Bisaccia G; De Luca A; Di Bella G; Gregori D; Perfetto F; Merlo M; Sinagra G; Iliceto S; Perazzolo Marra M; Corrado D; Ricci F; Cappelli F; Cipriani A
    Heart Rhythm; 2024 Jun; 21(6):725-732. PubMed ID: 38309449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
    Mints YY; Doros G; Berk JL; Connors LH; Ruberg FL
    ESC Heart Fail; 2018 Oct; 5(5):772-779. PubMed ID: 29916559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
    Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Remodeling Following Catheter Ablation for Atrial Fibrillation-Mediated Cardiomyopathy: Long-Term Follow-Up of CAMERA-MRI Study.
    Sugumar H; Prabhu S; Voskoboinik A; Young S; Gutman SJ; Wong GR; Parameswaran R; Nalliah CJ; Lee G; McLellan AJ; Taylor AJ; Ling LH; Kalman JM; Kistler PM
    JACC Clin Electrophysiol; 2019 Jun; 5(6):681-688. PubMed ID: 31221354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of increased interatrial septal thickness in patients with atrial fibrillation: a transesophageal echocardiographic study.
    López-Candales A; Grewal H; Katz W
    Echocardiography; 2005 May; 22(5):408-14. PubMed ID: 15901292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.
    Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M
    Eur J Prev Cardiol; 2024 Aug; 31(11):1410-1417. PubMed ID: 38456769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara P; Patel N; Venkatesh S; Samman-Tahhan A; Hammadah M; Kelli HM; Soliman EZ
    Eur Heart J Cardiovasc Imaging; 2017 Jul; 18(7):725-729. PubMed ID: 28379310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
    Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
    Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis.
    Di Bella G; Cappelli F; Licordari R; Piaggi P; Campisi M; Bellavia D; Minutoli F; Gentile L; Russo M; de Gregorio C; Perfetto F; Mazzeo A; Falletta C; Clemenza F; Vita G; Carerj S; Aquaro GD
    Amyloid; 2022 Sep; 29(3):197-204. PubMed ID: 35465808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.